Home > Research > Publications & Outputs > Understanding the natural progression in %FEV1 ...

Research

Electronic data

  • 860

    Final published version, 297 KB, PDF document

    Available under license: CC BY

Links

Text available via DOI:

View graph of relations

Understanding the natural progression in %FEV1 decline in patients with cystic fibrosis: a longitudinal study

Research output: Contribution to Journal/Magazine › Journal article › peer-review

Published

Standard

Understanding the natural progression in %FEV1 decline in patients with cystic fibrosis: a longitudinal study. / Taylor-Robinson, David; Whitehead, Margaret; Diderichsen, Finn et al.
In: Thorax, Vol. 67, No. 10, 2012, p. 860-866.

Research output: Contribution to Journal/Magazine › Journal article › peer-review

Harvard

Taylor-Robinson, D, Whitehead, M, Diderichsen, F, Olesen, HV, Pressler, T, Smyth, RL & Diggle, P 2012, 'Understanding the natural progression in %FEV1 decline in patients with cystic fibrosis: a longitudinal study', Thorax, vol. 67, no. 10, pp. 860-866. https://doi.org/10.1136/thoraxjnl-2011-200953

APA

Taylor-Robinson, D., Whitehead, M., Diderichsen, F., Olesen, H. V., Pressler, T., Smyth, R. L., & Diggle, P. (2012). Understanding the natural progression in %FEV1 decline in patients with cystic fibrosis: a longitudinal study. Thorax, 67(10), 860-866. https://doi.org/10.1136/thoraxjnl-2011-200953

Vancouver

Taylor-Robinson D, Whitehead M, Diderichsen F, Olesen HV, Pressler T, Smyth RL et al. Understanding the natural progression in %FEV1 decline in patients with cystic fibrosis: a longitudinal study. Thorax. 2012;67(10):860-866. doi: 10.1136/thoraxjnl-2011-200953

Author

Taylor-Robinson, David ; Whitehead, Margaret ; Diderichsen, Finn et al. / Understanding the natural progression in %FEV1 decline in patients with cystic fibrosis : a longitudinal study. In: Thorax. 2012 ; Vol. 67, No. 10. pp. 860-866.

Bibtex

@article{a3343934126a4075977b8fd3847f9b7f,
title = "Understanding the natural progression in %FEV1 decline in patients with cystic fibrosis: a longitudinal study",
abstract = "Forced expiratory volume in 1 s as a percentage of predicted (%FEV1) is a key outcome in cystic fibrosis (CF) and other lung diseases. As people with CF survive for longer periods, new methods are required to understand the way %FEV1 changes over time. An up to date approach for longitudinal modelling of %FEV1 is presented and applied to a unique CF dataset to demonstrate its utility at the clinical and population level.",
author = "David Taylor-Robinson and Margaret Whitehead and Finn Diderichsen and Olesen, {Hanne Vebert} and Tania Pressler and Smyth, {Rosalind L} and Peter Diggle",
year = "2012",
doi = "10.1136/thoraxjnl-2011-200953",
language = "English",
volume = "67",
pages = "860--866",
journal = "Thorax",
issn = "1468-3296",
publisher = "B M J PUBLISHING GROUP",
number = "10",

}

RIS

TY - JOUR

T1 - Understanding the natural progression in %FEV1 decline in patients with cystic fibrosis

T2 - a longitudinal study

AU - Taylor-Robinson, David

AU - Whitehead, Margaret

AU - Diderichsen, Finn

AU - Olesen, Hanne Vebert

AU - Pressler, Tania

AU - Smyth, Rosalind L

AU - Diggle, Peter

PY - 2012

Y1 - 2012

N2 - Forced expiratory volume in 1 s as a percentage of predicted (%FEV1) is a key outcome in cystic fibrosis (CF) and other lung diseases. As people with CF survive for longer periods, new methods are required to understand the way %FEV1 changes over time. An up to date approach for longitudinal modelling of %FEV1 is presented and applied to a unique CF dataset to demonstrate its utility at the clinical and population level.

AB - Forced expiratory volume in 1 s as a percentage of predicted (%FEV1) is a key outcome in cystic fibrosis (CF) and other lung diseases. As people with CF survive for longer periods, new methods are required to understand the way %FEV1 changes over time. An up to date approach for longitudinal modelling of %FEV1 is presented and applied to a unique CF dataset to demonstrate its utility at the clinical and population level.

U2 - 10.1136/thoraxjnl-2011-200953

DO - 10.1136/thoraxjnl-2011-200953

M3 - Journal article

C2 - 22555277

VL - 67

SP - 860

EP - 866

JO - Thorax

JF - Thorax

SN - 1468-3296

IS - 10

ER -